Keyphrases
Clinical Development
14%
Combined Modality Therapy
14%
Community Needs
14%
Complex Disease
100%
Developmental Stages
14%
Drug Testing
14%
Epigenetics
14%
ETS-related Gene
14%
Ewing Sarcoma
100%
Ewing-like
14%
EWS-ETS
14%
EWS-FLI1
28%
EWSR1-ETS
14%
Fusion Protein
14%
Gene Rearrangement
14%
Genetic Aberrations
14%
Human Disease
14%
In Vitro Model
14%
Joint Efforts
100%
Large Group
14%
Maintain Knowledge
14%
Molecular Pathogenesis
14%
Multiple Layers
100%
Novel Therapeutic Targets
14%
Novel Therapeutics
14%
Novel Therapies
14%
Oncoprotein
14%
Open Dialogue
14%
Permissiveness
14%
Preclinical Development
14%
Protein Activity
14%
RNA Sequencing (RNA-seq)
14%
Sarcoma
14%
Science Experts
14%
Susceptibility Loci
14%
Targeted Therapeutics
14%
Tissue Microenvironment
14%
Tumor Heterogeneity
28%
Variant Translocation
14%
INIS
animals
12%
communities
12%
data
12%
diseases
100%
drugs
12%
genes
12%
genetics
25%
humans
12%
in vitro
12%
interactions
25%
layers
100%
pathogenesis
12%
patients
12%
proteins
12%
sarcomas
100%
testing
12%
therapy
12%
tissues
12%
translocation
12%
Immunology and Microbiology
Developmental Stage
100%
Drug Screening
100%
Gene Rearrangement
100%
Preclinical Study
100%
Medicine and Dentistry
Chimeric Protein
14%
Diseases
100%
Drug Screening
14%
Ewing Sarcoma
100%
Gene Rearrangement
14%
In Vitro
14%
Molecular Pathology
14%
Oncoprotein
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Protein
14%
Connective Tissue Cancer
14%
Diseases
100%
Drug Screening
14%
Ewing Sarcoma
100%
Molecular Pathology
14%
Oncoprotein
14%
Biochemistry, Genetics and Molecular Biology
Animal Models
14%
Chimeric Protein
14%
Developmental Stage
14%
Drug Screening
14%
Epigenetics
14%
Ewing Sarcoma
100%
FLI1
28%
Gene Rearrangement
14%
Genetics
28%
Preclinical Study
14%